0000899243-23-002611.txt : 20230125
0000899243-23-002611.hdr.sgml : 20230125
20230125160021
ACCESSION NUMBER: 0000899243-23-002611
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230123
FILED AS OF DATE: 20230125
DATE AS OF CHANGE: 20230125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kuriakose Emil
CENTRAL INDEX KEY: 0001892413
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36644
FILM NUMBER: 23552479
MAIL ADDRESS:
STREET 1: 343 OYSTER POINT BLVD, SUITE 200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Calithera Biosciences, Inc.
CENTRAL INDEX KEY: 0001496671
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272366329
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 343 OYSTER POINT BLVD #200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-870-1000
MAIL ADDRESS:
STREET 1: 343 OYSTER POINT BLVD #200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-23
0
0001496671
Calithera Biosciences, Inc.
CALA
0001892413
Kuriakose Emil
C/O CALITHERA BIOSCIENCES, INC.
343 OYSTER POINT BLVD. #200
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
CHIEF MEDICAL OFFICER
Common Stock
2023-01-23
4
F
0
79
0.4461
D
3539
D
Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on January 23, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
Includes 125 shares acquired on each of June 10, 2022 and December 9, 2022, under the Company's 2014 Employee Stock Purchase Plan.
/s/ Emil Kuriakose
2023-01-25